Delirium and high fever are associated with subacute motor deterioration in parkinson disease: A nested case-control study

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Umemura, Atsushi ^a   Oeda, Tomoko ^a   Tomita, Satoshi ^a   Hayashi, Ryutaro ^a   Kohsaka, Masayuki ^a   Park, Kwiyoung ^a   Sugiyama, Hiroshi ^a   Sawada, Hideyuki ^a  

^a UTANO NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; C REACTIVE PROTEIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AGE; AGED; ARTICLE; BODY TEMPERATURE; BURN; CASE CONTROL STUDY; CELLULITIS; CHOLECYSTITIS; CONTROLLED STUDY; DELIRIUM; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FEVER; GASTROENTERITIS; GENDER; GOUT; HOEHN AND YAHR SCALE; HUMAN; INFLAMMATION; INFLUENZA; LENGTH OF STAY; LEUKOCYTE COUNT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; PARKINSON DISEASE; PNEUMONIA; PROSTATITIS; PROTEIN BLOOD LEVEL; PSYCHOSIS; PYELONEPHRITIS; QUALITY OF LIFE; UPPER RESPIRATORY TRACT INFECTION; COMPLICATION; MOTOR ACTIVITY; PATHOPHYSIOLOGY; RISK;

AGED; CASE-CONTROL STUDIES; DELIRIUM; FEMALE; FEVER; HUMANS; INFLAMMATION; MALE; MOTOR ACTIVITY; ODDS RATIO; PARKINSON DISEASE;

EID: 84902305798     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094944     Document Type: Article

References (33)

1. Nutt JG, Wooten GF (2005) Clinical practice. Diagnosis and initial management of Parkinson's disease. N Engl J Med 353: 1021-1027. (Pubitemid 41262336)
2. Jankovic J (2008) Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79: 368-376.
3. de Lau LM, Breteler MM (2006) Epidemiology of Parkinson's disease. Lancet Neurol 5: 525-535. (Pubitemid 44262284)
4. Zheng KS, Dorfman BJ, Christos PJ, Khadem NR, Henchcliffe C, et al. (2012) Clinical characteristics of exacerbations in Parkinson disease. Neurologist 18: 120-124.
5. Gerlach OH, Broen MP, Weber WE (2013) Motor outcomes during hospitalization in Parkinson's disease patients: a prospective study. Parkinsonism Relat Disord 19: 737-741.
6. Pott Godoy MC, Tarelli R, Ferrari CC, Sarchi MI, Pitossi FJ (2008) Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 131: 1880-1894. (Pubitemid 351957456)
7. Pott Godoy MC, Ferrari CC, Pitossi FJ (2010) Nigral neurodegeneration triggered by striatal AdIL-1 administration can be exacerbated by systemic IL-1 expression. J Neuroimmunol 222: 29-39.
8. Villarán RF, Espinosa-Oliva AM, Sarmiento M, De Pablos RM, Arqüelles S, et al. (2010) Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson's disease. J Neurochem 114: 1687-1700.
9. American Psychiatry Association (APA) (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn, American Psychiatry Association, Washington, DC.
10. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioral Disorders. Diagnostic Criteria for Research, WHO, Geneva.
11. Inouye SK, Rushing JT, Foreman MD, Palmer RM, Pompei P (1998) Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. J Gen Intern Med 13: 234-242. (Pubitemid 28169436)
12. McCusker J, Cole M, Dendukuri N, BelZile E, Primeau F (2001) Delirium in older medical inpatients and subsequent cognitive and functional status: a prospective study CMAJ 165: 575-583. (Pubitemid 32881560)
13. Fong TG, Jones RN, Shi P, Marcantonio ER, Yap L, et al. (2009) Delirium accelerates cognitive decline in Alzheimer disease. Neurology 72: 1570-1575.
14. Witlox J, Eurelings LS, de Jonghe JF, Kalisvaart KJ, Eikelenboom P, et al. (2010) Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA 304: 443-451.
15. Young J, Inouye SK (2007) Delirium in older people. BMJ 334: 842-846. (Pubitemid 46706931)
16. Maclullich AM, Ferguson KJ, Miller T, de Rooij SE, Cunningham C (2008) Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. J Psychosom Res 65: 229-238.
17. Daniel SE, Lees AJ (1993) Parkinson's Disease Society Brain Bank, London: overview and research. J Neural Transm (Suppl) 39: 165-172. (Pubitemid 23216938)
18. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, et al. (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25: 2649-2653.
19. Inouye SK, Foreman MD, Mion LC, Katz KH, Cooney LM Jr. (2001) Nurses' recognition of delirium and its symptoms: comparison of nurse and researcher ratings. Arch Intern Med 161: 2467-2473. (Pubitemid 33043120)
20. Lewis LM, Miller DK, Morley JE, Nork MJ, Lasater LC (1995) Unrecognized delirium in ED geriatric patients. Am J Emerg Med 13: 142-145.
21. Elie M, Rousseau F, Cole M, Primeau F, McCusker J, et al. (2000) Prevalence and detection of delirium in elderly emergency department patients. CMAJ 163: 977-981.
22. Inouye SK (2006) Delirium in older persons. N Engl J Med 354: 1157-1165.
23. Lieberman A (1998) Managing the neuropsychiatric symptoms of Parkinson's disease. Neurology (suppl 6): S33-38.
24. de Smet Y, Ruberg M, Serdaru M, Dubois B, Lhermitte F, et al. (1982) Confusion, dementia and anticholinergics in Parkinson's disease. J Neurol Neurosurg Psychiatry 45: 1161-1164. (Pubitemid 13166269)
25. Sawada H, Oeda T, Yamamoto K, Umemura A, Tomita S, et al. (2013) Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort study. BMC Neurol 13: 145. Available: http://www.biomedcentral.com/1471-2377/13/145. Accessed 12 October 2013.
26. Goetz CG (1999) Hallucinations in Parkinson's disease: the clinical syndrome. Adv Neurol 80: 419-423.
27. van Munster BC, Korevaar JC, Zwinderman AH, Levi M, Wiersinga WJ, et al. (2008) Time-course of cytokines during delirium in elderly patients with hip fractures. J Am Geriatr Soc 56: 1704-1709.
28. Cerejeira J, Firmino H, Vas-Serra A, Mukaetova-Ladinska EB (2010) The neuroinflammatory hypothesis of delirium. Acta Neuropathol 119: 737-754.
29. van Munster BC, Aronica E, Zwinderman AH, Eikelenboom P, Cunningham C, et al. (2011) Neuroinflammation in delirium: a postmortem case-control study. Rejuvenation Res 14: 615-622.
30. Kouti L, Noroozian M, Akhondzadeh S, Abdollahi M, Javadi MR, et al. (2013) Nitric oxide and peroxynitrite serum levels in Parkinson's disease: correlation of oxidative stress and the severity of the disease. Eur Rev Med Pharmacol Sci 17: 964-970.
31. Kanthasamy A, Jin H, Mehrotra S, Mishra R, Kanthasamy A, et al. (2010) Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease. Neurotoxicology 31: 555-561.
32. Farooqui T, Farooqui AA (2011) Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease. Parkinsons Dis 15: 247467. Available: http://www.hindawi.com/journals/pd/2011/247467. Accessed 15 February 2011.
33. Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, et al. (2010) The clinically important difference on the unified Parkinson's disease rating scale. Arch Neurol 67: 64-70.